SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009480
Filing Date
2023-03-23
Accepted
2023-03-23 16:06:57
Documents
15
Period of Report
2023-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20230323.htm   iXBRL 8-K 56238
2 EX-99.1 pepg-ex99_1.htm EX-99 254612
3 GRAPHIC img148377401_0.jpg GRAPHIC 4713
  Complete submission text file 0000950170-23-009480.txt   485431

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pepg-20230323_def.xml EX-101.DEF 13678
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pepg-20230323.xsd EX-101.SCH 2886
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pepg-20230323_lab.xml EX-101.LAB 17289
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pepg-20230323_pre.xml EX-101.PRE 13008
9 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20230323_htm.xml XML 6372
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 23756248
SIC: 2834 Pharmaceutical Preparations